Increasingly, advanced programmes are being designed around rapid, high-complexity DNA access from day one.
Therapeutics Development.
Trusted by therapeutics developers to deliver complex constructs under critical timelines.
NunaBio supported a UK therapeutics developer with rapid, high-precision manufacture of both minicircle and closed ended DNA constructs, delivering material at high purity and ahead of schedule.
Whilst ordering from standard suppliers would have delayed the client’s project, the speed at which NunaBio were able to provide the required material enabled the client to meet critical experimental timelines, with feedback praising the reliability and quality of the sequences produced.
Contract Research.
Sequences others cannot manufacture become viable, expanding what can be built.
NunaBio partnered with a leading research organisation, working on Huntingdon’s Disease, to create a bespoke, highly complex product that does not exist on the commercial market.
This proprietary product involved the manufacture of short, repetitive sequences of variable lengths, that support characterisation of disease stages and research into repeat expansion disorders. Due to the intricate nature of the sequences, standard DNA suppliers would typically be unable to accommodate their production.
Pharmaceuticals
Manufacturing.
Enabling rapid evaluation of high-fidelity templates for next-generation therapies.
Custom linear and circular sequences, including ultra-long polyA regions, were supplied to the client at milligram scale to facilitate mRNA therapeutic manufacturing. While conventional DNA manufacturers typically decline complex sequences and require extended lead times for mg-scale DNA, the NunaSynth platform enables expedited delivery of high-fidelity, intricate templates for advanced therapeutics.
